Caredx Investigation Continues
The investigation into CareDx, Inc. is progressing, led by former Louisiana Attorney General Charles C. Foti, Jr., a partner at the esteemed law firm Kahn Swick & Foti, LLC (KSF). This inquiry is particularly aimed at the actions of the company’s officers and directors concerning possible breaches of fiduciary duties and violations of laws at both state and federal levels.
Background of the Investigation
CareDx, Inc. has recently come under scrutiny after revealing that it received civil investigative demands from the U.S. Department of Justice (DOJ). These demands pertain to a False Claims Act investigation focusing on certain business practices relating to its kidney testing and phlebotomy services.
In late 2021, the company also reported it had received a subpoena from the SEC, which raised alarms about their accounting methods and public reporting practices. There are concerns about the transparency of operations and performance metrics disclosed to shareholders.
Financial Performance and Legal Challenges
Problems seem to have compounded for CareDx as they disclosed disappointing financial results. In late 2022, they reported a revenue decline of $1.7 million year-over-year from diagnostic solutions. Furthermore, operating costs surged by 14%, which starkly overshadowed income increases and doubled their operational losses from $8.7 million to $17.3 million.
This troubling trend has led to a class-action lawsuit against CareDx. The lawsuit alleges that the company violated federal securities laws by failing to communicate essential material information. Recently, a court denied CareDx's motion to dismiss the Second Amended Class Action Complaint, allowing it to proceed.
Focus of KSF's Investigation
KSF’s investigation is a critical examination of the conduct of CareDx's leadership. It centers on whether the actions taken by the officers and directors served the shareholders' best interests and complied with the legal standards set forth by governing bodies.
The law firm is keen on gathering information that might reveal whether CareDx’s officers or directors disregarded their legal and ethical responsibilities. Shareholders who might possess information valuable to KSF are encouraged to reach out.
How to Get Involved
If you have been a long-term shareholder or possess any pertinent information regarding CareDx that could assist with this investigation, you can contact KSF at no cost. Their toll-free number is 1-877-515-1850, where expert legal guidance is available.
About Kahn Swick & Foti, LLC
KSF is recognized as one of the leading boutique securities litigation law firms in the nation. They specialize in providing legal services to a diverse clientele, which includes public institutional investors, hedge funds, money managers, and individual retail investors. KSF is committed to recovering losses that stem from corporate misconduct or fraud perpetrated by publicly traded companies.
The firm operates in multiple states, including New York, California, Louisiana, and New Jersey, enhancing their capability to tackle complex legal issues across various jurisdictions.
Frequently Asked Questions
What is the focus of KSF's investigation into CareDx?
KSF is investigating whether CareDx's officers and directors breached their fiduciary duties or violated state and federal laws.
What legal issues is CareDx currently facing?
CareDx is facing a class-action lawsuit for failing to disclose material information and is under investigation by the DOJ and SEC.
How can shareholders assist in the investigation?
Shareholders can provide information to KSF by calling their toll-free number at 1-877-515-1850.
What are the financial concerns raised about CareDx?
CareDx has reported declining revenues and increasing operational losses, raising concerns about their business practices and financial health.
Who leads Kahn Swick & Foti, LLC?
Kahn Swick & Foti is led by Charles C. Foti, Jr., a former Attorney General of Louisiana, who is a partner at the firm.
